Aurora Cannabis (TSE:ACB) Hits New 52-Week Low at $5.37

Shares of Aurora Cannabis Inc (TSE:ACB) reached a new 52-week low on Tuesday . The company traded as low as C$5.37 and last traded at C$5.44, with a volume of 8727315 shares traded. The stock had previously closed at C$5.82.

A number of analysts have weighed in on the company. Stifel Nicolaus lowered Aurora Cannabis from a “hold” rating to a “sell” rating and reduced their target price for the stock from C$7.00 to C$5.00 in a research note on Monday, September 16th. Desjardins reduced their target price on Aurora Cannabis from C$16.50 to C$14.00 and set a “buy” rating on the stock in a research note on Friday, September 13th. Finally, CIBC reiterated a “neutral” rating and issued a C$7.00 target price on shares of Aurora Cannabis in a research note on Tuesday, September 24th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the company. Aurora Cannabis currently has a consensus rating of “Hold” and an average target price of C$12.00.

The company has a quick ratio of 0.98, a current ratio of 1.52 and a debt-to-equity ratio of 14.69. The business has a 50 day simple moving average of C$7.36 and a two-hundred day simple moving average of C$9.88. The firm has a market cap of $6.21 billion and a PE ratio of -18.76.

Aurora Cannabis Company Profile (TSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, from facility engineering and design to cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Recommended Story: What is the QQQ ETF?

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.